Pfizer May Have Plotted To Delay COVID Vaccine Until After 2020 Election, Congress Says
On Thursday, the GOP-led House Judiciary Committee announced that it received bombshell evidence that suggested Pfizer executives pushed to delay full testing for their company’s COVID vaccine until after the 2020 election.
British drugmaker GSK informed the panel that Philip Dormitzer, a former Pfizer executive who became a senior scientist at GSK, told colleagues at GSK that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
The Judiciary Committee, led by Chairman Jim Jordan (R-OH), said that it had sought information from GSK after The Wall Street Journal reported in March that U.S. prosecutors were looking into a tip from the company that came in “soon” after President Donald Trump won a second term in 2024.
The Journal noted that Trump, who lost to Joe Biden in the 2020 presidential contest, “for years has claimed that Pfizer sat on the positive results of clinical trials, which could have reflected well on his management of the pandemic and reassured voters as they headed to the polls. There has never been evidence to support the accusation, and the development of the Covid vaccines is widely viewed as a medical miracle, coming faster than any other vaccine in history.”
🚨 HUGE 🚨
New Information Suggests Senior Pfizer Executives Conspired to Delay COVID-19 Vaccine Clinical Testing to Influence 2020 Election.
One exec was so scared about this being investigated that he asked to be relocated to Canada!
MASSIVE SCANDAL uncovered by @Jim_Jordan. pic.twitter.com/pZKLAz1Wmx
— House Judiciary GOP 🇺🇸🇺🇸🇺🇸 (@JudiciaryGOP) May 15, 2025
(Read more from “Pfizer May Have Plotted To Delay COVID Vaccine Until After 2020 Election, Congress Says” HERE)
